Lipella Pharmaceuticals (NASDAQ: LIPO) reported Q2 2023 earnings per share (EPS) of -$0.27, up 35% year over year. Total Lipella Pharmaceuticals earnings for the quarter were -$1.54 million. In the same quarter last year, Lipella Pharmaceuticals's earnings per share (EPS) was -$0.20.
As of Q4 2023, Lipella Pharmaceuticals's earnings has grown year over year. Lipella Pharmaceuticals's earnings in the past year totalled -$3.68 million.
What was LIPO's revenue last quarter?
Lipella Pharmaceuticals (NASDAQ: LIPO) reported Q2 2023 revenue of $106.68 thousand up Infinity% year over year. In the same quarter last year, Lipella Pharmaceuticals's revenue was $0.00.
What was LIPO's revenue growth in the past year?
As of Q4 2023, Lipella Pharmaceuticals's revenue has grown 536.51% year over year. This is 437.01 percentage points higher than the US Biotechnology industry revenue growth rate of 99.5%. Lipella Pharmaceuticals's revenue in the past year totalled $375.73 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.